2018
DOI: 10.1016/j.ejso.2017.10.215
|View full text |Cite
|
Sign up to set email alerts
|

Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 79 publications
0
33
0
1
Order By: Relevance
“…Sentinel lymph node biopsy (SLNB) is used to stage the axilla in breast cancer patients with negative preoperative staging, and guides local and systemic treatment . Patients with positive sentinel nodes may require chemotherapy and axillary treatment with either surgical clearance or axillary radiotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…Sentinel lymph node biopsy (SLNB) is used to stage the axilla in breast cancer patients with negative preoperative staging, and guides local and systemic treatment . Patients with positive sentinel nodes may require chemotherapy and axillary treatment with either surgical clearance or axillary radiotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…Performing axillary lymph node dissection as a substitute for sentinel lymph node biopsy even in the absence of radioisotope is no longer accepted. This explains the need for providing other effective alternatives for SLN detection in areas lacking availability of radioisotopes …”
Section: Discussionmentioning
confidence: 99%
“…As in melanoma, sentinel lymph node mapping is considered the gold standard for staging of the axilla in breast carcinoma 12 13. The greater incidence of breast cancer, compared with other tumor types, has led to a vastly increased experience with sentinel lymph node mapping and the establishment of prognostically relevant groups based on metastasis size.…”
Section: Sentinel Lymph Node Mapping: the Melanoma And Breast Cancer mentioning
confidence: 99%